Amalgamated Bank I Bio, Inc. Transaction History

Amalgamated Bank

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$0.23 - $0.46 $5,984 - $11,968	-26,018 Closed	0 $0
Q1 2022 Jun 30, 2022	SELL	$0.3 - $0.61 $635 - $1,292	-2,119 Reduced 7.53%	26,018 $11,000
Q4 2021 Feb 15, 2022	SELL	$0.55 - $1.04 $528 - $999	-961 Reduced 3.3%	28,137 $15,000
Q3 2021 Oct 29, 2021	SELL	$1.06 - $1.52 $1,399 - $2,006	-1,320 Reduced 4.34%	29,098 $31,000
Q2 2021 Aug 16, 2021	BUY	$1.22 - $1.65 $7,426 - $10,043	6,087 Added 25.02%	30,418 $46,000
Q4 2020 Feb 12, 2021	BUY	$1.05 - $2.24 $25,547 - $54,501	24,331 New	24,331 $25,000

Ticker IBIO
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 9,006,580
Market Cap $24M
Description
iBio, Inc., a biotechnology company, provides contract development and manufacturing services to collaborators and third-party customers in the United States. The company operates in two segments: Biopharmaceuticals and Bioprocessing. Its lead therapeutic candidate is IBIO-100 that is being advanced for investigational new drug development for t...

Get notified when there are updates to the investment portfolio of Amalgamated Bank, based on Form 13F filings with the SEC.

Stay updated on Amalgamated Bank with notifications on news.